Ajanta Pharma Ltd.
BSE: 532331 | Sector: Health care |
NSE: AJANTPHARM | ISIN Code: INE031B01049 |
BSE 00:00 | 16 Apr | 1728.60 |
25.55 (1.50%) |
OPEN
1705.00 |
HIGH
1750.00 |
LOW
1703.00 |
NSE 00:00 | 16 Apr | 1730.90 |
21.30 (1.25%) |
OPEN
1710.00 |
HIGH
1741.60 |
LOW
1701.05 |
OPEN | 1705.00 |
PREVIOUS CLOSE | 1703.05 |
VOLUME | 3469 |
52-Week high | 1883.00 |
52-Week low | 1283.10 |
P/E | 24.48 |
Mkt Cap.(Rs cr) | 14,961 |
Buy Price | 0.00 |
Buy Qty | 0.00 |
Sell Price | 0.00 |
Sell Qty | 0.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Ajanta Pharma Ltd. (AJANTPHARM) - Nine Monthly Result
Particulars (![]() |
Dec '20 | Dec '19 | Dec '18 | Dec '17 | Dec '16 |
Net Sales/Income From Operations | 1970.52 | 1635.74 | 1359.09 | 1367.85 | 1404.21 |
Other Income | 102.24 | 130.10 | 98.96 | 69.26 | 59.59 |
Total Income | 2072.76 | 1765.84 | 1458.05 | 1437.11 | 1463.80 |
Total Expenditure | 1300.69 | 1210.22 | 945.10 | 938.70 | 911.31 |
Operating Profit | 772.07 | 555.62 | 512.95 | 498.41 | 552.49 |
Interest | 4.72 | 6.17 | 0.21 | 0.19 | 0.87 |
Gross Profit | 767.35 | 549.45 | 512.74 | 498.22 | 551.62 |
Depreciation | 82.01 | 66.40 | 51.70 | 41.22 | 40.61 |
PBT | 685.34 | 483.05 | 461.04 | 457.00 | 511.01 |
Tax | 148.13 | 125.60 | 100.18 | 94.00 | 117.53 |
Net Profit/(Loss) | 520.86 | 352.62 | 350.39 | 349.02 | 391.84 |
Minority Interest After NP | - | - | - | - | - |
Net Profit after Minority Interest | - | - | - | - | - |
Exceptional Items | 0.00 | -1.03 | 0.00 | 0.00 | 0.00 |
Profit After Exceptional Items | 520.86 | 353.65 | 350.39 | 349.02 | 391.84 |
Equity Share Capital | 17.39 | 17.54 | 17.69 | 17.69 | 17.69 |
Reserves Excluding Revaluation Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
EPS | |||||
Basic EPS | 60.20 | 40.41 | 39.81 | 39.66 | 44.53 |
Public Share Holding | |||||
No Of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
Share Holding (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Promoters and Promoter Group Shareholding | |||||
a) Pledged/Encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of Shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of Shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
b) Non-encumbered | |||||
- Number of Shares (Crores) | 0 | 0 | 0 | 0 | 0 |
- Per. of shares (as a % of the total sh. of prom. and promoter group) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
- Per. of shares (as a % of the total Share Cap. of the company) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Note : | PBT include deferred tax and fringe benefit tax Net profit figures include extra-ordinary items income/expenditure. |
Quick Links for Ajanta Pharma:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices